<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03050333</url>
  </required_header>
  <id_info>
    <org_study_id>ALB-RME-2013-01</org_study_id>
    <nct_id>NCT03050333</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Endoscopic Resection</brief_title>
  <official_title>Efficacy and Safety of Endoscopic Resection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>EDUARDO ALBENIZ</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundacion Miguel Servet</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fundacion Miguel Servet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      An observational, prospective, multicentre and international study. This will be a
      non-interventional study to evaluate the efficacy and safety of endoscopic resection of
      gastrointestinal lesions and to determine what are the factors related to complications, and
      to describe these lesions according to the different morphologic and histologic
      classifications.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 25, 2013</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of complete resections without recurrence</measure>
    <time_frame>6 month post-endoscopic resection</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Endoscopic Resection</condition>
  <condition>Gastrointestinal Neoplasms</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with a clinical indication for endoscopic resection at the different participating
        centers will be consecutively included in this study.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female and male patients who are at least 18 years old.

          -  Clinical indication for endoscopic exam and endoscopic resection

          -  Patients must freely accept their involvement in this study. They shall give a written
             informed consent

        Exclusion Criteria:

          -  Patients who do not desire to be included in this study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>EDUARDO ALBENIZ, MD</last_name>
    <email>edualbeniz@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Eduardo Albeniz Arbizu</name>
      <address>
        <city>Pamplona</city>
        <state>Navarra</state>
        <zip>31008</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>EDUARDO ALBENIZ, MD</last_name>
      <email>edualbeniz@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>FERRAN CAPDEVILA, PHARMD</last_name>
      <email>fcapdevb@navarra.es</email>
    </contact_backup>
    <investigator>
      <last_name>EDUARDO ALBENIZ, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <link>
    <url>http://navarrabiomed.es</url>
  </link>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 3, 2017</study_first_submitted>
  <study_first_submitted_qc>February 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 10, 2017</study_first_posted>
  <last_update_submitted>February 9, 2017</last_update_submitted>
  <last_update_submitted_qc>February 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Fundacion Miguel Servet</investigator_affiliation>
    <investigator_full_name>EDUARDO ALBENIZ</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastrointestinal Neoplasms</mesh_term>
    <mesh_term>Digestive System Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

